I’m a Woman Seeking Answers

You’re not crazy. You’re not alone.
You’re in the right place.

Menopause can feel confusing and lonely. We’re here to help you feel understood, supported, and connected to a real community that cares.

I’m a Healthcare Provider

Empower your practice with
menopause expertise.

Support your patients with confidence. Access expert tools, trusted training, and join a professional network focused on better menopause care.

Articles

Contributed by Members of the Menopause Association

Menopause - The Latest News and Resources

FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women

A high-profile FDA panel convened in July 2025 sparked a pivotal public reckoning with the way hormone replacement therapy (HRT) for menopause is regulated and understood in the U.S. Leading experts challenged outdated warnings rooted in decades-old studies, highlighting mounting evidence for the safety and benefits of modern HRT—especially when initiated early. The meeting underscored both the scientific and human costs of regulatory inertia, signaling a major shift in national menopause care.

Read more

Correcting the Record: Re-evaluating the Risks and Benefits of Menopausal HRT

Dr. Hirsch challenged the outdated fear surrounding hormone therapy, especially the legacy of the WHI study. She called for removing the black box warning and advocated for patient-centered care, emphasizing the importance of educating both clinicians and the public with current evidence.
Read more 
 

Beyond the WHI: Modernizing FDA Warnings on Hormone Therapy

Dr. Levy addressed the FDA’s black box warning, arguing it fails to reflect modern science. She focused on the distinction between systemic and local hormones and urged the FDA to revise its labeling to prevent unnecessary suffering and restore trust in HRT.
Read more 
 

Women’s Access and Policy Reform: Why Black Box Warnings Must Change

Dr. Pinkerton delivered a powerful call to action, urging removal of the black box warning on hormone therapies. She emphasized the proven benefits of early intervention and called the outdated label a barrier to equitable, evidence-based care for millions of women.

Read more 
 

Timing Matters: When and How HRT Delivers the Greatest Benefit

Dr. Simon highlighted how the timing of hormone therapy dramatically affects risk and benefit. With proper initiation and patient selection, he argued, HRT is both safe and effective—and current policy should reflect this individualized, modern approach to care.

Read more 
 

More Than Symptoms: HRT and Mental Health in Menopause

Dr. Sarrel reframed menopause as a public-health crisis when left untreated. He emphasized HRT’s role not just in symptom relief, but in improving mood and reducing anxiety, calling for broader recognition of its mental health benefits in regulatory policy.

Read more 
 

New Frontiers: Menopause, HRT, and the Female Brain

Dr. Brinton presented compelling research linking menopause-related hormone loss to Alzheimer’s risk. She explained how timely hormone therapy may protect brain function and called for smarter regulation that reflects newly emerging neurobiological evidence.

Read more 
 

Bones at Risk: Estrogen, Osteoporosis, and Why Timing Counts

Dr. Wright focused on estrogen’s bone-preserving power, presenting HRT as the most effective therapy for preventing fractures. She argued that the black box warning deters life-saving interventions and must be removed to improve aging outcomes for women.

Read more 
 

Testosterone Inequality: The Gender Gap in Hormone Care

Dr. Casperson highlighted gender disparities in hormone access, particularly the FDA’s failure to approve testosterone for women. She underscored how regulatory bias leaves women under-treated and pushed for fair, evidence-based therapeutic options.

Read more 
 

Debunking Myths: Why the Black Box on Vaginal Estrogen Endangers Women

Dr. Minkin debunked myths about vaginal estrogen and condemned the black box warning as unsupported and damaging. She emphasized that low-dose vaginal therapy is safe and critical, and that outdated warnings harm both access and public perception.

Read more 
 

Skepticism to Science: The Real Risks and Benefits of Local Estrogen Therapy

Dr. Rubin argued that vaginal estrogen is both essential and safe, yet remains stigmatized by outdated labeling. She showed the costs—clinical and economic—of withholding proven therapies, and advocated for removing regulatory barriers to access.

Read more 
 

All-Cause Mortality and CVD: The Timing Hypothesis in HRT

Dr. Hodis emphasized that hormone therapy, when started early, improves survival and lowers cardiovascular risk. He advocated for a stratified approach to HRT labeling and urged the FDA to align regulatory guidance with decades of timing-specific data.

Read more 
 

Menopause - News and Articles Sourced From Around the Globe

providers

Videos Provided by Members

About Stress Urinary Incontinence
Dr. George K. Ibrahim
Biltmore Restorative Medicine

Slings and Mesh for Treating Incontinence
Dr. George K. Ibrahim
Biltmore Restorative Medicine

Hormone Replacement Therapy Benefits for Women
Dr. Julian R. Gershon Jr.
Aspen Institute for Antiaging and Regenerative Medicine

Empowering Women Through Hormone Replacement Therapy in 2025
Dr. Julian R. Gershon Jr.
Aspen Institute for Antiaging and Regenerative Medicine

What is perimenopause
Dr. Amanda Tracy
Naturopathic Doctor

Supplements in Perimenopause
Dr. Amanda Tracy
Naturopathic Doctor